🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Einav Nili Gal‐Yam

Sheba Medical Center

ORCID: 0000-0003-1059-7923

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial”.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Annals of Oncology(2023)10.1016/j.annonc.2023.08.003

N/A

1.4DataRank · unranked

61 citations

L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more

The human tumor microbiome is composed of tumor type–specific intracellular bacteria

Science(2020)10.1126/science.aay9189

N/A

1.2DataRank · unranked

2272 citations

Ilana Livyatan, Garold Fuks, Nancy Gavert, Yaara Zwang, Leore T. Geller +56 more

Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions

Cell(2022)10.1016/j.cell.2022.09.005

N/A

0DataRank · unranked

510 citations

Gregory D. Sepich‐Poore, Ilana Livyatan, Omer Asraf, Cameron Martino, Deborah Nejman +21 more